Financial News
Press Releases about Vectivbio Holding Ag
![](https://mms.businesswire.com/media/20230629311475/en/618520/22/IRWD_Logo_Color_Vertical_RD_RGB.jpg)
![](https://ml.globenewswire.com/media/b891a6ca-8c42-4311-8c1a-7e0f923983d7/small/vectivbio-logo-rgb-color-png.png)
![](https://mms.businesswire.com/media/20230616065227/en/618520/22/IRWD_Logo_Color_Vertical_RD_RGB.jpg)
![](https://mms.businesswire.com/media/20230606005859/en/1115287/22/Latest_KSF_M%26A.jpg)
![](https://mms.businesswire.com/media/20230525005780/en/1115287/22/Latest_KSF_M%26A.jpg)
![](https://mms.businesswire.com/media/20230522005384/en/1567526/5/Firm_Logo-with_Investor_Law_Firm.jpg)
![](https://ml.globenewswire.com/media/b891a6ca-8c42-4311-8c1a-7e0f923983d7/small/vectivbio-logo-rgb-color-png.png)
From VectivBio AG
Via GlobeNewswire
![](https://ml.globenewswire.com/media/b891a6ca-8c42-4311-8c1a-7e0f923983d7/small/vectivbio-logo-rgb-color-png.png)
From VectivBio AG
Via GlobeNewswire
![](https://ml.globenewswire.com/media/b891a6ca-8c42-4311-8c1a-7e0f923983d7/small/vectivbio-logo-rgb-color-png.png)
![](https://ml.globenewswire.com/media/b891a6ca-8c42-4311-8c1a-7e0f923983d7/small/vectivbio-logo-rgb-color-png.png)
![](https://ml.globenewswire.com/media/b891a6ca-8c42-4311-8c1a-7e0f923983d7/small/vectivbio-logo-rgb-color-png.png)
![](https://ml.globenewswire.com/media/b891a6ca-8c42-4311-8c1a-7e0f923983d7/small/vectivbio-logo-rgb-color-png.png)
VectivBio Publishes Invitation to the Extraordinary General Meeting of Shareholders
November 16, 2022
From VectivBio AG
Via GlobeNewswire
![](https://ml.globenewswire.com/media/b891a6ca-8c42-4311-8c1a-7e0f923983d7/small/vectivbio-logo-rgb-color-png.png)
VectivBio to Present at the 2022 Jefferies London Healthcare Conference
November 09, 2022
From VectivBio AG
Via GlobeNewswire
![](https://ml.globenewswire.com/media/b891a6ca-8c42-4311-8c1a-7e0f923983d7/small/vectivbio-logo-rgb-color-png.png)
![](https://ml.globenewswire.com/media/b891a6ca-8c42-4311-8c1a-7e0f923983d7/small/vectivbio-logo-rgb-color-png.png)
VectivBio Announces Closing of $125 Million Underwritten Offering of Ordinary Shares
October 18, 2022
From VectivBio AG
Via GlobeNewswire
![](https://ml.globenewswire.com/media/b891a6ca-8c42-4311-8c1a-7e0f923983d7/small/vectivbio-logo-rgb-color-png.png)
VectivBio Announces Pricing of $125 Million Underwritten Offering of Ordinary Shares
October 13, 2022
From VectivBio AG
Via GlobeNewswire
![](https://ml.globenewswire.com/media/b891a6ca-8c42-4311-8c1a-7e0f923983d7/small/vectivbio-logo-rgb-color-png.png)
![](https://ml.globenewswire.com/media/b891a6ca-8c42-4311-8c1a-7e0f923983d7/small/vectivbio-logo-rgb-color-png.png)
From VectivBio AG
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.